Adherence to guideline-directed medical and device Therapy in outpAtients with heart failure with reduced ejection fraction: The ATA study
Date
2020Author
Altinsoy, Meltem
Kocabas, Umut
Kivrak, Tarik
Oztekin, Gulsum Meral Yilmaz
Tanik, Veysel Ozan
Ozdemir, Ibrahim Halil
Kaya, Ersin
Yuce, Elif Ilkay
Demir, Fulya Avci
Dogdus, Mustafa
Ustundag, Songul
Ozyurtlu, Ferhat
Karagoz, Ugur
Karakus, Alper
Urgun, Orsan Deniz
Sinan, Umit Yasar
Mutlu, Inan
ŞEN, TANER
ASTARCIOĞLU, MEHMET ALİ
Kinik, Mustafa
Tok, Ozge Ozden
Uygur, Begum
Yeni, Mehtap
Alan, Bahadir
Dalgic, Onur
Sariturk, Cagla
Altay, Hakan
Pehlivanoglu, Seckin
Metadata
Show full item recordAbstract
Objective: Despite recommendations from heart failure guidelines on the use of pharmacologic and device therapy in patients with heart failure with reduced ejection fraction (HFrEF), important inconsistencies in guideline adherence persist in practice. The aim of this study was to assess adherence to guideline-directed medical and device therapy for the treatment of patients with chronic HFrEF (left ventricular ejection fraction <= 40%).
Collections
- Makale [92796]